(Q36649096)

15 August 2017

1 reference

title

Acute treatment of mania: an update on new medications (English)

1 reference

15 August 2017

4

Guohua Xia

1 reference

15 August 2017

6

Joseph R Calabrese

1 reference

15 August 2017

Prashant Gajwani

1

1 reference

15 August 2017

David E Kemp

series ordinal

2

1 reference

15 August 2017

David J Muzina

series ordinal

3

1 reference

15 August 2017

Keming Gao

series ordinal

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Current Psychiatry Reports

15 August 2017

published in

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

504-509

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-006-0058-3

15 August 2017

exact match

0 references

cites work

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-006-0058-3

Valproate in the treatment of acute mania. A placebo-controlled study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-006-0058-3

Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

12 December 2020

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

1 reference

12 December 2020

Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial

1 reference

12 December 2020

Clozapine for treatment-refractory mania

1 reference

12 December 2020

The emerging epidemiology of hypomania and bipolar II disorder

1 reference

12 December 2020

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

1 reference

12 December 2020

Impact of bipolar disorder on a U.S. community sample.

1 reference

12 December 2020

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

1 reference

12 December 2020

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

1 reference

12 December 2020

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group

1 reference

12 December 2020

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

1 reference

12 December 2020

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.

1 reference

12 December 2020

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

1 reference

12 December 2020

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania

1 reference

12 December 2020

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

1 reference

12 December 2020

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

1 reference

12 December 2020

Pharmacologic agents for the treatment of acute bipolar mania.

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

12 December 2020

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.

1 reference

12 December 2020

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder

1 reference

12 December 2020

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

1 reference

12 December 2020

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

1 reference

12 December 2020

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

1 reference

12 December 2020

Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.

1 reference

12 December 2020

Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies

1 reference

12 December 2020

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

1 reference

12 December 2020

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

1 reference

12 December 2020

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

1 reference

12 December 2020

10.1007/S11920-006-0058-3

Identifiers

DOI

1 reference

15 August 2017

1 reference